N/A
N=31
High Velocity Nasal Insufflation (Hi-VNI) Use in Upper Airway Surgery
Upper Airway Surgery
Bottom Line
View on ClinicalTrials.gov: NCT05090852 ↗Enrolled (actual)
31
Serious AEs
0.0%
Results posted
Sep 2022
Primary outcome: Primary: Surgical Case Completion Rate Using HVNI With or Without Converting to Alternative Mode of Oxygenation — 19; 7; 5 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Hi-VNI (Device)
- Age
- Adult, Older Adult · 22+ yrs
- Sex
- All
- Sponsor
- Natasha Mirza
- Primary completion
- Sep 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Surgical Case Completion Rate Using HVNI With or Without Converting to Alternative Mode of Oxygenation |
19; 7; 5 | — |
Summary
The goals of this study are to establish the efficacy of Hi-VNI (High Velocity Nasal Insufflation) in upper airway surgery from the anesthesiologist's and surgeon's perspectives, and to describe the ideal patient and the ideal pathology as well as suitable clinical scenarios when this oxygenation technique should be selected.
Eligibility Criteria
Inclusion Criteria
- Scheduled to undergo elective upper airway surgery at the University of Pennsylvania
Exclusion Criteria
- Underlying medical conditions in which brief periods of hypoxemia or hypercarbia are not well tolerated
- Coronary artery disease
- Severe heart failure with EF 40)
- At high risk for aspiration
- Taken to OR for urgent or emergent upper airway surgery
Data sourced from ClinicalTrials.gov (NCT05090852). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.